Menu

• Ask a Health Expert about LABORATORY TEST INTERFERENCE
• Post Your Side Effect related to LABORATORY TEST INTERFERENCE
• LABORATORY TEST INTERFERENCE and FDA Warnings
• LABORATORY TEST INTERFERENCE in Patients Wiki
• Report LABORATORY TEST INTERFERENCE in Drug Side Effect Survey

LABORATORY TEST INTERFERENCE side effect

What is LABORATORY TEST INTERFERENCE ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Welchol Side Effects Report #5526187-5
Physician from CZECH REPUBLIC reported WELCHOL problem on Nov 05, 2007. Female patient, 16 years of age, weighting 125.4 lb, was diagnosed with hypercholesterolaemia and was treated with WELCHOL. After drug was administered, patient experienced the following problems/side effects: laboratory test interference, platelet aggregation, thrombocytopenia, . WELCHOL dosage: unknown. During the same period patient was treated with ESTRADIOL. Patient was hospitalized. Patient recovered.

Methylene Side Effects Report #5464030-3
METHYLENE BLUE problem was reported by a Physician from UNITED STATES on Sept 10, 2007. Female patient was diagnosed with vasoplegia syndrome and was treated with METHYLENE BLUE. After drug was administered, patient experienced the following problems/side effects: laboratory test interference, . METHYLENE BLUE dosage: 2 MG/KG PU. During the same period patient was treated with NOREPINEPHRINE, VASOPRESSIN. Patient recovered.

Methylene Side Effects Report #5464032-7
Physician from UNITED STATES reported METHYLENE BLUE problem on Sept 10, 2007. Female patient was diagnosed with vasoplegia syndrome and was treated with METHYLENE BLUE. After drug was administered, patient experienced the following problems/side effects: laboratory test interference, . METHYLENE BLUE dosage: 2 MG/KG PU. During the same period patient was treated with NOREPINEPHRINE, VASOPRESSIN. Patient recovered.

Claravis Side Effects Report #5426126-1
CLARAVIS problem was reported by a Health Professional from UNITED STATES on Aug 08, 2007. Female patient, 24 years of age, weighting 134.9 lb, was treated with CLARAVIS. After drug was administered, patient experienced the following problems/side effects: laboratory test interference, treatment noncompliance, . CLARAVIS dosage: 30 MG, BID, ORAL. Patient recovered.


Cisplatin Side Effects Report #5353597-1
Health Professional from UNITED STATES reported CISPLATIN problem on June 08, 2007. Male patient, weighting 164.9 lb, was diagnosed with tonsil cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: laboratory test interference, neutrophil count decreased, . CISPLATIN dosage: X100 MG/M2 IV Q 3 WKS. During the same period patient was treated with CETUXIMAB. Patient was hospitalized. Patient recovered.

Nexium Side Effects Report #5312313-X
NEXIUM problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 19, 2006. Female patient, 48 years of age, weighting 112.0 lb, was diagnosed with dyspepsia, barrett's oesophagus and was treated with NEXIUM. After drug was administered, patient experienced the following problems/side effects: laboratory test interference, . NEXIUM dosage: unknown. Patient recovered.

Vytorin Side Effects Report #5648987-3
Consumer or non-health professional from UNITED STATES reported VYTORIN problem on Mar 03, 2008. Male patient, 69 years of age, weighting 120.0 lb, was diagnosed with blood cholesterol increased and was treated with VYTORIN. After drug was administered, patient experienced the following problems/side effects: hypoaesthesia, laboratory test interference, muscular weakness, pain, . VYTORIN dosage: unknown. Patient recovered.

Taxol Side Effects Report #5669868-5
TAXOL problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 14, 2008. Female patient, weighting 128.3 lb, was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, laboratory test interference, . TAXOL dosage: 256 MG. Patient was hospitalized. Patient recovered.

Cefamezin Side Effects Report #5464294-6
Pharmacist from JAPAN reported CEFAMEZIN problem on Sept 18, 2007. Male patient, 64 years of age, was treated with CEFAMEZIN. After drug was administered, patient experienced the following problems/side effects: eosinophil count decreased, laboratory test interference, platelet count decreased, white blood cell count increased, . CEFAMEZIN dosage: unknown. During the same period patient was treated with LANSOPRAZOLE, ACECOL, AMLODIPINE, LIVALO, FLIVAS. Patient was hospitalized. Patient recovered.


Natalizumab Side Effects Report #5405056-5
NATALIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2007. Female patient, 47 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: infusion related reaction, laboratory test interference, pyrexia, . NATALIZUMAB dosage: 300 MG;QM;IV. Patient recovered.

Thalomid Side Effects Report #5442941-2
Physician from CANADA reported THALOMID problem on Aug 23, 2007. Female patient, 37 years of age, was diagnosed with multiple myeloma and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: blood human chorionic gonadotropin increased, laboratory test interference, . THALOMID dosage: 200 MG, 4 IN 1 D, ORAL ; 100 MG, QHS, ORAL. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISONE. Patient recovered.

Fastic Side Effects Report #5772262-X
FASTIC problem was reported by a Physician from JAPAN on June 02, 2008. Male patient was diagnosed with diabetes mellitus, hypertension, angina pectoris and was treated with FASTIC. After drug was administered, patient experienced the following problems/side effects: erythema multiforme, laboratory test interference, pyrexia, rash, . FASTIC dosage: 270 MG/DAY. During the same period patient was treated with BASEN, ASPIRIN, LOCHOL, HERBESSER, FAMOTIDINE, PLETAL. Patient was hospitalized. Patient recovered.

Zantac Side Effects Report #5786884-3
Consumer or non-health professional from UNITED STATES reported ZANTAC problem on June 24, 2008. Female patient, 40 years of age, weighting 125.0 lb, was diagnosed with gastrooesophageal reflux disease and was treated with ZANTAC. After drug was administered, patient experienced the following problems/side effects: amphetamines positive, laboratory test interference, . ZANTAC dosage: unknown. Patient recovered.

Thalomid Side Effects Report #5725749-X
THALOMID problem was reported by a Physician from UNITED STATES on Apr 21, 2008. Female patient, 50 years of age, was diagnosed with multiple myeloma and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: blood human chorionic gonadotropin increased, laboratory test interference, . THALOMID dosage: unknown. During the same period patient was treated with DEXAMETHASONE, ACYCLOVIR, FOLIC ACID, NIFENEX. Patient recovered.


Thalomid Side Effects Report #5291434-4
Physician from CANADA reported THALOMID problem on Mar 23, 2007. Female patient, 37 years of age, was diagnosed with multiple myeloma and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: blood human chorionic gonadotropin increased, laboratory test interference, pregnancy test false positive, . THALOMID dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISONE. Patient recovered.

Thalomid Side Effects Report #5594203-0
THALOMID problem was reported by a Physician from CANADA on Jan 09, 2008. Female patient, 37 years of age, was diagnosed with multiple myeloma and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: blood human chorionic gonadotropin abnormal, ill-defined disorder, laboratory test interference, . THALOMID dosage: 200 MG, 4 IN 1 D, ORAL. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISONE. Patient recovered.

Thalomid Side Effects Report #5600984-X
Physician from CANADA reported THALOMID problem on Jan 09, 2008. Female patient, 37 years of age, was diagnosed with multiple myeloma and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: blood human chorionic gonadotropin negative, blood human chorionic gonadotropin positive, laboratory test interference, . THALOMID dosage: 200 MG, 4 IN 1 D, ORAL, 100 MG, QHS, ORAL. During the same period patient was treated with CYCLOPHOSPHAMIDE, PREDNISONE. Patient recovered.

Jantoven Side Effects Report #5494144-3
JANTOVEN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 02, 2007. Female patient, 55 years of age, was diagnosed with protein c deficiency and was treated with JANTOVEN. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, international normalised ratio decreased, laboratory test interference, venous thrombosis limb, . JANTOVEN dosage: 5 MG ALTERNATING WITH 7.5 MG, QD, PO. During the same period patient was treated with WARFARIN, ASCORBIC ACID, BIOTIN. Patient was hospitalized. Patient recovered.

Cervidil Side Effects Report #5450730-8
Consumer or non-health professional from UNITED KINGDOM reported CERVIDIL problem on Sept 03, 2007. Female patient, 29 years of age, weighting 227.1 lb, was diagnosed with labour induction and was treated with CERVIDIL. After drug was administered, patient experienced the following problems/side effects: anaemia, laboratory test interference, postpartum haemorrhage, uterine atony, . CERVIDIL dosage: 10 MG ONCE VG. During the same period patient was treated with INTRAVENOUS FLUIDS, OXYTOCIN. Patient recovered.


Ambisome Side Effects Report #5461121-8
AMBISOME problem was reported by a Physician from UNITED STATES on Sept 18, 2007. Female patient was treated with AMBISOME. After drug was administered, patient experienced the following problems/side effects: device interaction, laboratory test interference, . AMBISOME dosage: }5MG/KG. Patient recovered.

Velcade Side Effects Report #5384934-X
Physician from UNITED STATES reported VELCADE problem on June 29, 2007. Male patient, 42 years of age, weighting 220.0 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: coma, encephalopathy, laboratory test interference, . VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with PREVACID, LISINOPRIL, COREG, RENAGEL, AMBIEN. Patient was hospitalized. Patient recovered.

Ecural Side Effects Report #5385983-8
ECURAL problem was reported by a Physician from GERMANY on June 26, 2007. Female patient was diagnosed with dermatitis and was treated with ECURAL. After drug was administered, patient experienced the following problems/side effects: adrenal suppression, laboratory test interference, . ECURAL dosage: unknown. Patient recovered.

Velcade Side Effects Report #5384934-X
Physician from UNITED STATES reported VELCADE problem on June 29, 2007. Male patient, 42 years of age, weighting 220.0 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: coma, encephalopathy, laboratory test interference, . VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with PREVACID, LISINOPRIL, COREG, RENAGEL, AMBIEN. Patient was hospitalized. Patient recovered.

Ecural Side Effects Report #5385983-8
ECURAL problem was reported by a Physician from GERMANY on June 26, 2007. Female patient was diagnosed with dermatitis and was treated with ECURAL. After drug was administered, patient experienced the following problems/side effects: adrenal suppression, laboratory test interference, . ECURAL dosage: unknown. Patient recovered.

Boniva Side Effects Report #5772460-5
Pharmacist from BELGIUM reported BONIVA problem on June 03, 2008. Female patient, 65 years of age, was diagnosed with osteoporosis, diabetes mellitus and was treated with BONIVA. After drug was administered, patient experienced the following problems/side effects: coma, hypoglycaemia, laboratory test interference, . BONIVA dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, MESALAMINE, SALAZOPYRINE, SULFAPYRIDINE, INSULIN. Patient was hospitalized. Patient died on 10/01/2007.

Neupogen Side Effects Report #5744188-9
NEUPOGEN problem was reported by a Physician from SWEDEN on May 12, 2008. Female patient, 48 years of age, weighting 207.2 lb, was diagnosed with blood stem cell harvest and was treated with NEUPOGEN. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, chest pain, laboratory test interference, troponin increased, white blood cell count increased, . NEUPOGEN dosage: unknown. During the same period patient was treated with NORVASC, OLMETEC, ESCITALOPRAM. Patient recovered.

Enalapril Side Effects Report #5746789-0
Health Professional from GERMANY reported ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE problem on May 02, 2008. Female patient, 65 years of age, was diagnosed with hypertension and was treated with ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE. After drug was administered, patient experienced the following problems/side effects: gastritis erosive, hepatic neoplasm, laboratory test interference, . ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE dosage: 1 DF QD10-25 MG TABLET ORAL. Patient recovered.

Cetuximab Side Effects Report #5696574-3
CETUXIMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 04, 2008. Male patient, 48 years of age, weighting 191.6 lb, was diagnosed with neoplasm malignant and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: atelectasis, bronchospasm, laboratory test interference, lung abscess, lung consolidation, lymphadenopathy, malignant neoplasm progression, metastases to lung, pleural effusion, . CETUXIMAB dosage: 500 MG/M2 EVERY 2 WEEKS IV. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, DOCUSATE, PROMETHAZINE W, SYMBICORT, ALBUTEROL. Patient was hospitalized. Patient recovered.